Pildu Jeong
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Expression of RPL9 predicts the recurrence of non-muscle invasive bladder cancer with BCG therapy.
Journal: Urologic oncology
Published: October 19, 2021
A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy.
Journal: International journal of molecular sciences
Published: January 09, 2021
Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
Journal: International journal of oncology
Published: October 28, 2020
Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer.
Journal: Investigative and clinical urology
Published: October 20, 2020
Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer.
Journal: Journal of clinical medicine
Published: September 03, 2020
Parathyroid hormone is associated with prostate cancer.
Journal: Prostate international
Published: November 17, 2019
A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone.
Journal: Investigative and clinical urology
Published: September 10, 2019
A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer.
Journal: Oncology letters
Published: June 27, 2019
Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
Journal: Clinical genitourinary cancer
Published: January 07, 2019
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.
Journal: Urologic oncology
Published: August 19, 2018
Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
Journal: International journal of cancer
Published: June 14, 2018
Last Updated: 09/26/2026